Patrick Sweeney, MD
Ophthalmology · Sunnyvale, TXNPI 1043206352
Payments from drug & device makers
Across 72 payments — averaging $95.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$4K
- Bausch & Lomb Americas Inc.$598
- Rxsight Inc$535
- Alcon$345
- Lensar, Inc.$314
- AbbVie$167
- plus $449 from 9 others
What the payments were for
- Speaking & faculty fees$3,13646%
- Travel & lodging$5518%
- Food & beverage$3,19146%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 16 | $4,469 |
| Bausch & Lomb Americas Inc. | 8 | $598 |
| Rxsight Inc | 10 | $535 |
| Alcon | 9 | $345 |
| Lensar, Inc. | 2 | $314 |
| AbbVie(2 entities) | 8 | $167 |
| Johnson & Johnson Surgical Vision, Inc. | 7 | $122 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $111 |
| Sight Sciences, Inc. | 3 | $50 |
| Eyepoint US, Inc. | 2 | $38 |
| Carl Zeiss Meditec, Inc. | 1 | $36 |
| Sun Pharmaceutical Industries Inc. | 2 | $35 |
| Tarsus Pharmaceuticals, Inc. | 1 | $25 |
| Harrow Eye, LLC | 1 | $16 |
| NEW World Medical,inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iStent inject Trabecular Micro-Bypass Stent System$3,551
- enVista MX60 IOL$522
- RXSIGHT CONTACT LENS$362
- RXSIGHT INJECTOR CARTRIDGE$362
- RXSIGHT INJECTOR HANDPIECE$362
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$362
- LENSAR LASER SYSTEM$314
- iStent inject W$259
- KXL System$259
- Photrexa$259
- LIGHT ADJUSTABLE LENS (LAL)$246
- enVista Aspire IOL$150
- iStent Trabecular Micro-Bypass System Model iS3$134
- Clareon$121
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$116
- AcrySof IQ PanOptix UV IOL$116
- ENVISTA ENVY IOL$113
How this compares
$6,878 in reported general payments places this provider in the 75th percentile of 1,355 ophthalmology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 19 | $297 |
| Timolol Maleate | 27 | $149 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Sunnyvale
- Charles WykoffBellaire$73.4M
- David BrownHouston$51.7M
- Sunil PatelAbilene$11.1M
- Chirag JhaveriAustin$9.4M
- Robert WongAustin$6.6M
- Fuad MakkoukAustin$6.6M
- Patrick WilliamsArlington$6.6M
- Ashkan AbbeyDallas$5.7M
- Karl CsakyDallas$4.9M
- Michael SingerSan Antonio$4.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.